Romesh R. Subramanian
Io Therapeutics (United States)
ORCID: 0000-0001-5586-9895Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice”.
Monica Yao, John Hall, Emma O’Donnell, Reshmii Venkatesan, Sean Spring +12 more
Frank S. French, Elizabeth M. Wilson, Jiann An Tan, Christopher W. Gregory, Romesh R. Subramanian +4 more
Jiann-an Tan, Christopher W. Gregory, O. Harris Ford, Romesh R. Subramanian, Haian Fu +4 more